Free Trial

Ontrak (OTRK) Competitors

Ontrak logo
$1.57 +0.01 (+0.58%)
As of 11:24 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

OTRK vs. BNR, MRAI, ENZ, BRTX, MGRX, SSY, BGLC, ACON, DHAC, and VSEE

Should you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include Burning Rock Biotech (BNR), Marpai (MRAI), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), Digital Health Acquisition (DHAC), and Vsee Health (VSEE). These companies are all part of the "healthcare" industry.

Ontrak vs.

Burning Rock Biotech (NASDAQ:BNR) and Ontrak (NASDAQ:OTRK) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, community ranking, institutional ownership, risk, profitability and valuation.

Burning Rock Biotech has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.3, meaning that its stock price is 130% more volatile than the S&P 500.

Ontrak received 33 more outperform votes than Burning Rock Biotech when rated by MarketBeat users. Likewise, 59.38% of users gave Ontrak an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote.

CompanyUnderperformOutperform
Burning Rock BiotechOutperform Votes
5
31.25%
Underperform Votes
11
68.75%
OntrakOutperform Votes
38
59.38%
Underperform Votes
26
40.63%

30.0% of Burning Rock Biotech shares are owned by institutional investors. Comparatively, 12.9% of Ontrak shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by insiders. Comparatively, 1.9% of Ontrak shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Burning Rock Biotech has a net margin of -83.50% compared to Ontrak's net margin of -237.77%. Burning Rock Biotech's return on equity of -60.68% beat Ontrak's return on equity.

Company Net Margins Return on Equity Return on Assets
Burning Rock Biotech-83.50% -60.68% -42.30%
Ontrak -237.77%-171.34%-113.42%

Ontrak has a consensus price target of $45.00, indicating a potential upside of 2,784.62%. Given Ontrak's stronger consensus rating and higher probable upside, analysts plainly believe Ontrak is more favorable than Burning Rock Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Burning Rock Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Ontrak
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Ontrak had 5 more articles in the media than Burning Rock Biotech. MarketBeat recorded 5 mentions for Ontrak and 0 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.00 beat Ontrak's score of -0.29 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company Overall Sentiment
Burning Rock Biotech Neutral
Ontrak Neutral

Ontrak has lower revenue, but higher earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Burning Rock Biotech$515.82M0.06-$92.07M-$1.88-1.65
Ontrak$10.85M0.61-$27.92M-$15.81-0.10

Summary

Ontrak beats Burning Rock Biotech on 10 of the 18 factors compared between the two stocks.

Get Ontrak News Delivered to You Automatically

Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OTRK vs. The Competition

MetricOntrakhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$6.58M$2.06B$5.37B$8.39B
Dividend YieldN/A6.99%5.22%4.10%
P/E Ratio-0.1516.0626.8419.71
Price / Sales0.613.40392.34117.39
Price / CashN/A9.3238.2534.62
Price / Book0.283.966.794.50
Net Income-$27.92M$87.49M$3.23B$248.18M
7 Day Performance-9.51%-7.77%4.07%1.14%
1 Month Performance8.33%-4.21%12.52%15.20%
1 Year Performance-61.19%-29.28%16.83%6.56%

Ontrak Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OTRK
Ontrak
2.5265 of 5 stars
$1.57
+0.6%
$45.00
+2,768.1%
-61.2%$6.56M$10.85M-0.15250News Coverage
Earnings Report
Gap Up
BNR
Burning Rock Biotech
0.4426 of 5 stars
$2.46
+5.6%
N/A-59.2%$25.20M$515.82M-0.821,390Upcoming Earnings
MRAI
Marpai
N/A$1.34
+3.1%
N/A-34.0%$19.96M$34.87M-0.51150
ENZ
Enzo Biochem
N/A$0.33
-14.8%
N/A-69.0%$17.03M$29.09M0.00520Gap Down
High Trading Volume
BRTX
BioRestorative Therapies
3.3258 of 5 stars
$1.85
+2.8%
$18.00
+873.0%
+23.0%$13.88M$401,000.00-1.217Analyst Revision
Gap Down
MGRX
Mangoceuticals
0.1827 of 5 stars
$1.72
-2.0%
N/A-98.7%$8.89M$615,873.00-0.303Earnings Report
SSY
SunLink Health Systems
N/A$0.89
-2.6%
N/A+42.5%$6.27M$31.23M6.361,376News Coverage
Analyst Forecast
Gap Up
BGLC
BioNexus Gene Lab
0.2595 of 5 stars
$3.07
+15.0%
N/A-44.9%$5.52M$9.51M0.0030Negative News
Earnings Report
ACON
Aclarion
1.6392 of 5 stars
$7.60
+7.0%
$11,758.50
+154,617.1%
-99.8%$4.42M$45,724.000.007Positive News
Earnings Report
DHAC
Digital Health Acquisition
N/A$1.17
-3.3%
N/A-91.4%$4.22MN/A0.002,021
VSEE
Vsee Health
1.1856 of 5 stars
$1.15
-2.1%
$5.00
+336.7%
N/A$4.13M$6.38M0.00N/AGap Up

Related Companies and Tools


This page (NASDAQ:OTRK) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners